Skin+CELL 390697

Skin+CELL
Informacje o programie
Aplikuj teraz!
Nazwa
Skin+CELL
Id
390697
Kraj
GB Wielka Brytania
Kategoria
Zdrowie i uroda
Data startu
2025-08-19
Url strony startowej
www.skinandcell.com

Krótki opis

Skin+CELL is a premium skincare brand created by Incanthera PLC, a British biotechnology company specialising in dermatology innovation. Rooted in science, Skin+CELL combines advanced formulation and delivery technologies to restore, protect, and enhance skin health. With a foundation in clinical expertise, the brand brings cutting-edge biotech into luxury skincare, offering products designed to deliver visible, proven results.

Pokaż więcej

Prowizja segmentu General

iSales
15,00%
Sales
15,00%
  • Kody rabatowe
    Tak
  • Banery
    Nie
  • Linki tekstowe
    Nie
  • Niestandardowy html
    Nie
  • DeepLinking
    Dozwolone
Okres plików cookie
30 dni
Polityka słów kluczowych
Brak
Waluta
GBP
Średni EPC
0,00 GBP
Powrót
Pokaż więcej

Skin+CELL is a luxury skincare brand developed by Incanthera PLC, a British dermatology company with roots in the University of Bradford’s Institute of Cancer Therapeutics. Backed by 25 years of biotech research, Skin+CELL combines academic credibility with luxury formulation.

At the heart of the range is patented Inside/Out & Residual Phase Technology, proven to deliver niacinamide (Vitamin B3) deep into the skin barrier where it energises cells, protects mitochondrial DNA, and supports natural repair processes. Independent studies show a 6.5x improvement in UV protection and enhanced cellular energy within just six days.

All products – including the flagship B3 Serum, Face Cream, Eye Cream, Body Cream, and Hand Cream – are vegan, cruelty-free, and designed with both efficacy and luxury in mind. Skin+CELL blends cutting-edge science with indulgent textures and sustainable gold packaging, offering visible results and proven credibility.

Join the affiliate program via Skimlinks and introduce your readers to a pioneering biotech-driven brand redefining luxury skincare.